Investment
Cassidy Bio launched with Ahren among its investors to develop gene editing therapies.
Cassidy Bio
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Cassidy Bio
Constructive Bio
Mentee Robotics
Adrestia Therapeutics
Ahren first fund close